Shattuck Labs

Filed a patent for "trim7 inhibitors and uses thereof" on Fri, August 18, 2023

Filed a patent for "trim7 inhibitors and uses thereof" on Fri, August 18, 2023

Filed a patent for "trim7 inhibitors and uses thereof" on Mon, March 4, 2024

Filed a patent for "trim7 inhibitors and uses thereof" on Mon, March 4, 2024

Filed a patent for "trim7 inhibitors and uses thereof" on Mon, April 8, 2024

Filed a patent for "trim7 inhibitors and uses thereof" on Mon, April 8, 2024

Filed a patent for "combination therapy with a sirpa-based chimeric protein and azacitidine" on Mon, July 31, 2023

Filed a patent for "combination therapy with a sirpa-based chimeric protein and azacitidine" on Mon, November 13, 2023

Filed a patent for "combination therapy with a sirpa-based chimeric protein and azacitidine" on Tue, December 12, 2023

Filed a patent for "combination therapy with a sirpa-based chimeric protein and azacitidine" on Wed, February 28, 2024

Filed a patent for "combination therapy with a sirpa-based chimeric protein and azacitidine" on Tue, June 4, 2024

Filed a patent for "methods of treating cancer with a sirp1a-based chimeric protein" on Mon, February 13, 2023

Filed a patent for "treatment of b cell-mediated diseases by activating cd20-targeted gamma delta t cells" on Tue, March 14, 2023

Filed a patent for "treatment of b cell-mediated diseases by activating cd20-targeted gamma delta t cells" on Mon, April 17, 2023

Filed a patent for "methods of treating cancer with a sirp1a-based chimeric protein" on Fri, May 12, 2023

Filed a patent for "fusion proteins for the treatment of obesity and diabetes" on Mon, December 5, 2022

Filed a patent for "fusion proteins for the treatment of obesity and diabetes" on Mon, August 28, 2023

Filed a patent for "fusion proteins for the treatment of cardiometabolic diseases" on Thu, August 8, 2024

Filed a patent for "fusion proteins for the treatment of cardiometabolic diseases" on Thu, July 4, 2024

Filed a patent for "sirp1a - and cd40l-based chimeric proteins" on Thu, August 11, 2022

Filed a patent for "multispecific heterodimeric proteins" on Thu, September 8, 2022

Filed a patent for "b7h3-targeted gamma delta t cell modulation" on Mon, November 7, 2022

Filed a patent for "fusion proteins for the treatment of nonalcoholic steatohepatitis" on Mon, December 5, 2022

Filed a patent for "heterodimeric proteins and uses thereof" on Thu, July 13, 2023

Filed a patent for "homodimeric and heterodimeric proteins comprising butyrophilin" on Thu, December 28, 2023